OPY Acquisition I registered to offer 10 million units at $10 each. A unit consists of one share of Class A common stock and one-half of a warrant.
The new SPAC’s sponsor is controlled and managed by Oppenheimer Alternative Investment Management.
OPY I is focused on healthcare assets in the United States, Europe and Israel.
The new SPAC is led by Cahirman and CEO Jonathan Siegel, the founder and CEO of JBS Healthcare Ventures.
Oppenheimer and Lake Street are joint book-running managers of the offering. The underwriters’ over-allotment option covers up to an additional 1.5 million units.
The SPAC in the filing said it has applied for a Nasdaq listing but has not yet selected a ticker symbol. Read more.
